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CLINICAL SCIENCE
Predictors of the risk of falls among elderly with
chronic atrial fibrillation
Angela Cristina Silva dos Santos, Moacyr Roberto Cuceˆ Nobre, Amit Nussbacher, Giselle Helena de Paula
Rodrigues, Otavio Celso Eluf Gebara, Joa˜o Batista Carvalho Serro Azul, Mauricio Wajngarten
Faculdade de Medicina da Universidade de Sa˜o Paulo, Heart Institute, Sa˜o Paulo/SP, Brazil.
OBJECTIVES: Though elderly persons with chronic atrial fibrillation have more comorbidities that could limit
indications for the chronic use of anticoagulants, few studies have focused on the risk of falls within this particular
group. To evaluate the predictors of the risk of falls among elderly with chronic atrial fibrillation, a cross-sectional,
observational study was performed.
METHODS: From 295 consecutive patients aged 60 years or older with a history of atrial fibrillation who were
enrolled within the last 2 years in the cardiogeriatrics outpatient clinic of the Instituto do Corac¸a˜o do Hospital das
Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo, 107 took part in this study. Their age was 77.9¡6.4
years, and 62 were female. They were divided into two groups: a) no history of falls in the previous year and b) a
history of one or more falls in the previous year. Data regarding the history of falls and social, demographic,
anthropometric, and clinical information were collected. Multidimensional assessment instruments and ques-
tionnaires were applied.
RESULTS: At least one fall was reported in 55 patients (51.4%). Among them, 27 (49.1%) presented recurrent falls,
with body lesions in 90.4% and fractures in 9.1% of the cases. Multivariate logistic regression showed that self-
reported difficulty maintaining balance, use of amiodarone, and diabetes were independent variables associated
with the risk of falls, with a sensitivity of 92.9% and a specificity of 44.9%.
CONCLUSION: In a group of elderly patients with chronic atrial fibrillation who were relatively independent and
able to attend an outpatient clinic, the occurrence of falls with recurrence and clinical consequences was high.
Difficulty maintaining balance, the use of amiodarone and a diagnosis of diabetes mellitus were independent
predictors of the risk for falls. Thus, simple clinical data predicted falls better than objective functional tests.
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INTRODUCTION
Atrial fibrillation (AF) and falls are common among the
elderly, which has increasing relevance as the life expec-
tancy of the population rises.
Not only do structural and functional alterations of the
cardiovascular system upon aging predispose patients to
AF, but they also reduce the capacity of hemodynamic
tolerance to arrhythmia, which may lead to syncope and fall
(1,2). The proportion of patients with relevant and highly
fall-related functional disabilities following ischemic stroke
related to AF may reach 59% (3).
Anticoagulation therapy is characterized by the strategy
of preventing thromboembolic events in elderly persons
with AF (4), but there is no consensus about the risk of its
use among patients with a history of falls, particularly in
recurrent cases of falls.
In patients with AF who are at a high risk for falls, Gage
et al. (5) showed that warfarin is related to mortality
associated with intracranial hemorrhage, but not to the
occurrence of intracranial hemorrhage. Despite that, the use
of anticoagulants was still beneficial owing to the high risk
of embolic stroke in this group.
A meta-analysis of antithrombotic therapy in elderly
patients at risk for falls concluded that the propensity for
falling in elderly patients should not be an important factor
when deciding whether a patient is a good candidate for the
anticoagulation treatment for AF (6). However, in the
randomized controlled trials evaluated in the meta-analysis,
patients may have been monitored more intensely than is
usual in clinical practice.
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Recently, in a study that included 4,093 patients older
than 80 years who were carefully monitored by an
anticoagulation clinic, the rate of bleeding was low,
suggesting that age itself should not be considered a
contraindication to treatment. However, a history of two
or more falls in a year was independently associated with
bleeding risk, as assessed by Cox regression analysis (7).
Guidelines for the prevention of falls in the elderly
recommend a series of instruments that should be applied
in individuals at risk of falling (8,9). However, a thorough
history, including questions about previous falls, medica-
tions, and balance, could be used for fall risk assessment
(10).
Thus, the issue of anticoagulation treatment of patients
with atrial fibrillation to prevent embolic stroke vis-a`-vis the
risk of falls has not been fully established in real-life elderly
patients. To evaluate predictors of falls among elderly
patients with chronic atrial fibrillation and indications for
anticoagulant therapy, a cross-sectional, observational study
was designed.
METHODS
A cross-sectional, observational study design was used.
The project was approved by the Scientific and Ethics
Committees of InCor-HCFMUSP (Scientific: PROTOCOL
SDC 2775/06/020, approved on 20/04/2006, and Ethics:
PROTOCOL No. 450/06, approved on 25/05/2006), and all
participants agreed to participate and signed an Informed
Consent Form.
Male and female patients aged 60 years or older with a
diagnosis of AF from the cardiogeriatrics outpatient clinic of
the Instituto do Coracao of the Hospital das Clı´nicas da
Faculdade de Medicina da Universidade de Sa˜o Paulo
(InCor-HCFMUSP) were recruited from their regular
ambulatory visit or summoned through telephone calls
from the outpatient clinic database registry of patients with
AF from September 2006 to May 2007, in order of arrival.
The selected patients were divided into two groups: a)
those with no history of falls in the previous year and b) those
with a history of one or more falls in the previous year.
Data regarding the history of falls and social, demo-
graphic, anthropometric, and clinical information were
collected. Furthermore, multidimensional assessment
instruments and questionnaires were applied. The history
of falls included the occurrence, number, local, character-
istics and consequences of falls (according to the definition
of Tinetti et al. (11) within the previous 12 months. Social
and demographic data included gender, age, marital status,
education level, people living in the same dwelling,
remuneration and professional activity. Anthropometric
data included weight, height, and body mass index (12).
Patients were further classified by whether they were
symptomatic, their eating habits, physical exercise habits,
smoking status, abuse of alcohol, medications used, and the
presence of cardiovascular diagnoses and comorbidities.
The physical examination, performed by the same physi-
cian, included simplified and systematized assessments of
cranial pairs, ocular movements, pyramidal signals, muscle
tonus and strength, reflexes and motor coordination,
sensitivity and proprioception, and the Romberg balance
test.
The following questionnaires and instruments validated
in Portuguese were used: Brazilian Functional Assessment
Questionnaire (BOMFAQ; Brazilian version of the OARS)
(13,14), Mini Mental State Examination (MMSE) (15,16),
Primary Care Evaluation for Mental Disorders (Prime MD)
(17,18,19), and Health Assessment Questionnaire
(HAQ)(20).
Sensorial assessment was performed by inquiring about
hearing conditions with the following question (21,22): ‘‘Do
you feel that you have experienced hearing loss?’’ Visual
assessment included campimetry and the Snellen scale test
(Herman Snellen, 1862) (23).
Balance and gait were assessed by applying the Berg
Functional Balance Scale (24,25), Performance-Oriented
Mobility Assessment (POMA) (26,27), Balance POMA and
Gait POMA, and Timed Up & Go (TUG) (28).
Statistical analysis
Classification variables were descriptively presented in
contingency tables comprising absolute (n) and relative (%)
frequencies. The associations among variables were
assessed with the chi-square test, likelihood test, or
Fisher’s exact test. Quantitative variables were presented
descriptively in tables, including mean and standard
deviation or median, minimum and maximum values.
Means were compared using the Student’s t-test or the
Wilcoxon rank-sum test. Values of p,0.05 were considered
statistically significant (29). Significant variables in the
univariate analysis were used in the regression model
adjustment to determine the sensitivity, specificity, esti-
mated probability of falls and odds ratios. The logistic
regression model was used to examine the relationships
between independent variables for the risk of falling. All
significant variables (p#0.05) and the interactions between
them were used to obtain a selection for the multivariate
model. We opted not to correct the critical value of p in the
function of multiple comparisons because the non-signifi-
cant variables were not included and were deemed
irrelevant to those that remained in the model, which
meant that the variables in the model did not require
correction. All significant variables in the univariate
analysis were adjusted in the logistic regression model
and related according to the ‘‘stepwise’’ procedure. The
variables that remained in the model were independent
predictor variables.
RESULTS
From the approximately 3,000 patients/year enrolled in
the cardiogeriatrics outpatient clinic of the InCor-
HCFMUSP, all 295 patients aged 60 years or older with a
history of atrial fibrillation who were registered in the 24
months prior to the period of clinical evaluation, which was
September 2006 to May 2007, were eligible to participate in
the study. Between the date of registration and the date of
evaluation, 26 patients died, 97 were not available through
the telephone numbers given to the institution, 11 patients
did not show up on the day of evaluation, 15 could not
participate due to living outside of Sa˜o Paulo, 36 were
excluded because they lacked the clinical conditions
required, and three refused to participate. Patients who
were not contacted by telephone after three attempts on
different days and times were excluded.
Ultimately, 107 patients took part in the full study
(Figure 1).
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They had an advanced age (77.9¡6.4 years) and a
predominance of shared dwellings (81.3%) and female
gender (57.9%). Most patients reported cardiovascular
symptoms (82.2%), were sedentary (80.4%), and used four
or more medications (87%). The most frequent diagnoses
were arterial hypertension (91%), osteoarthritis (47.7%),
dyslipidemia (46.7%), New York Heart Association class
I/II heart failure (41%), obesity (30.8%), diabetes mellitus
(18.7%), and heart failure class III (12.2%). The presence of
four or more comorbidities was frequent (44.9%). Patients
were divided and compared according to the history of falls
in the previous year (Table 1).
Occurrence of falls: One fall was reported in 55 patients
(51.4%). Of these, 49.1% presented recurrent falls, 32.7% fell
at home, and 28.9% fell on the street. The most frequent
reasons for falling were trips (35.3%) and slips (23.5%).
Dizziness and vertigo caused falls only in 6% of the
reports. The falls had consequences of body lesions in 90.4%
and fractures in 9.1% (five cases). Sixty percent of the
fractures were in the pelvis, and these led to hospitalization
in 7.7% (four cases) of the falling episodes.
Demographic data: There was no significant difference
regarding the occurrence of falls between the genders
(54.8% in female patients and 46.7% in male patients).
Only 19% of the patients lived alone, and 6% were single
or had never lived with partners. However, there was no
significant relationship between the occurrence of falls and
marital status, scholarship or income level, nor was there
Figure 1 - Study design.
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any association between the occurrence of falls and age or
BMI.
Clinical data: There was a significant correlation between
the occurrence of falls and the presence of clinical
symptoms (p = 0.015), mainly palpitations (p= 0.044), and
tiredness (p = 0.001). There was no significant relationship
between falling and a sedentary lifestyle, smoking, or
alcohol consumption.
Regarding the use of medications, 86.9% of the patients
used four or more medications, and only 2.8% (three
patients) did not use any medication. There was no
significant correlation between the occurrence of falls and
the number of medications used.
There was a significant correlation between the occur-
rence of falls and the use of anticonvulsants and benzodia-
zepines (p = 0.0410) and amiodarone (p = 0.0046), despite the
infrequent use of these drugs.
Among the diagnoses, there were significant relationships
between falling and congestive heart failure class III
(p= 0.009) and systolic hypertension (p= 0.034).
Among the comorbidities, type 2 diabetes mellitus was
the only condition with a significant correlation with the
occurrence of falls (p = 0.015). Decreased muscle strength in
the upper or lower limbs was also associated with the
occurrence of falls.
Questionnaires and instruments:
There was a significant association between the occur-
rence of falls and the domain of daily life activities of the
BOMFAQ (OARS), which revealed correlations between
falling and difficulty eating (p= 0.004), bathing without
assistance (p= 0.026), getting to the bathroom in time
(p= 0.009), preparing meals (p= 0.035), and trimming toe-
nails (p= 0.049). Furthermore, low life satisfaction (p = 0.007),
Table 1 - Characteristics and results of the elderly population with AF.
Variable FALL TOTAL p-value
NO YES
Female 28 45.16% 34 54.84% 62 0.283 *
Age (years) 77. 07 + 6. 58 78. 46 + 6. 29 77. 86 + 6. 42 0.276 #
BMI (kg/m2) 28 (19 - 55) 26 (19 - 38) 27 (19 - 55) 0.444 ##
Visual deficiency 32 42.11% 44 57.89% 76 0.005 *
Hearing deficiency 19 45.24% 23 54.76% 42 0.029 **
Physical activity 10 45.45% 12 54.55% 22 0.705 *
Symptoms 39 43.33% 48 53.33% 90 0.015 *
Palpitations 25 41.67% 35 58.33% 60 0.044 *
Tiredness 28 37.33% 47 62.67% 75 0.001 *
Paresthesias 16 38.10% 26 61.90% 42 0.037 *
Cephalea 4 26.67% 11 73.33% 15 0.041 *
Syncopes 0 0.00% 5 100.00% 5 0.027 ***
Muscle strength
Hand grip 19 45.24% 30 71.43% 42 0.021 ***
Quadrı´ceps 17 40.48% 25 59.52% 42 0.001 **
CHF FC I/II 22 50.00% 22 50.00% 44 0.934 *
Dilated myocardiopathy 26 39.39% 40 60.61% 66 0.085 *
Mitral failure 11 55.00% 9 45.00% 20 0.586 *
Coronary failure 5 29.41% 12 70.59% 17 0.077 *
CHF FC III 2 15.38% 11 84.62% 13 0.009 *
Tricuspid failure 7 53.85% 6 46.15% 13 0.739 *
Aortic failure 6 85.71% 1 14.29% 7 0.112 ***
Previous AMI 1 16.67% 5 83.33% 6 0.205 ***
COMORBIDITIES
Obesity 17 51.52% 16 48.48% 33 0.731 *
Diabetes mellitus 5 25.00% 15 75.00% 20 0.015 *
Neuropathies 6 30.00% 14 70.00% 20 0.052 *
COPD 6 33.33% 12 66.67% 18 0.131 *
Depression 8 47.06% 9 52.94% 17 0.824 *
Thyropathies 8 47.05% 9 52.94% 17 0.487 **
Peripheral vascular disease 9 60.00% 6 40.00% 15 0.381 *
Rheumatological diseases 3 33.33% 6 66.67% 9 0.488 ***
Chronic renal failure 3 37.50% 5 62.50% 8 0.716 ***
Gastric disorders 1 14.29% 6 85.71% 7 0.113 ***
Prostatism 5 71.43% 2 28.57% 7 0.265 ***
Pulmonary hypertension 2 28.57% 5 71.43% 7 0.437 ***
Neoplasia 2 33.33% 4 66.67% 6 0.678 ***
Epilepsy 2 66.67% 1 33.33% 3 0.598 ***
Scores
HAQ 0.72 0-2.25) 1.20 (0-2.88) 0.97 (0-2.88) 0,002* ##
MMSE 25 (9-30) 23.98(7-30) 24.47(7-30) 0,1761 ##
Timed Up & Go 11 (6 - 30) 13 (8 - 56) 12 (6 - 56) 0.063 ##
Gait POMA 11 (5 - 13) 11 (2- 12) 11 (2 - 13) 0.148 ##
Balance POMA 16 (8 - 16) 15 (1 - 16) 16 (1 - 16) 0.018 ##
Berg Balance Scale 51 (20 - 56) 51 (15 - 56) 51 (15 - 56) 0.224 ##
*Chi-square test **Likelihood ratio test *** Fisher’s exact test.
# Student’s t-test ## Wilcoxon’s rank sum test.
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perception of poor health quality (p= 0.0001), a sense of
uselessness (p= 0.005), hearing difficulties in noisy environ-
ments (p = 0.023), deglutition (p= 0.043), and balance diffi-
culties (p= 0.0001) were also significantly associated with
falls.
The relationships between the occurrence of falls and the
Mini-mental questionnaire scores were not significant.
However, the occurrence of falls was significantly asso-
ciated with major depression due to physical illness,
dysthymia and panic disorder according to the Prime MD,
as well as with the HAQ scores.
There was a significant association between hearing or
vision deficiencies and the occurrence of falls. From the
balance and gait tests, only the score of the Balance POMA
test revealed an association with the occurrence of falls.
Logistic regression
The logistic regression model was used to examine the
relationships between independent variables on the risk of
falling. All significant variables (p#0.05) and the interac-
tions between them were used in the multivariate model.
The following independent variables were identified by
logistic regression analysis: use of antiarrhythmics (amio-
darone), difficulty maintaining balance as assessed by the
BOMFAQ questionnaire, and the presence of diabetes
mellitus. The sensitivity was 92.9%, and the specificity
44.9%.
A patient with these three independent variables had a
97% chance of falling within the next year (Table 2).
Simulating possible results revealed that 1) patients taking
amiodarone who had diabetes mellitus had an 86% chance
of falling within the next year; 2) those on amiodarone and
presenting balance difficulty, 89%; and 3) those with
diabetes and balance alterations, 85%. Patients not present-
ing any of these variables had a 16.4% chance of falling
within a year (Table 3). The odds ratios for falls in one year
adjusted for all significant variables in the logistic regression
model indicated that the use of amiodarone increased the
risk of falls in one year seven times (odds ratio = 6.952);
diabetes mellitus increased the risk five times (odds
ratio = 4.909); and self-reported difficulty maintaining bal-
ance increased the risk six times (odds ratio = 5.862).
Similarly, the positive likelihood ratios showed that the
increased the risk of falling within the next year five times
(positive likelihood ratio = 5). Positive likelihood ratio =
sensitivity/1-specificity = 45/7= 5; negative likelihood
ratio = 1-sensitivity/specificity = 55/93= 0.6.
DISCUSSION
The present study shows that use of amiodarone, the
presence of diabetes mellitus and self-reported difficulty
maintaining balance (as assessed by the BOMFAQ ques-
tionnaire) increase the likelihood of falls in elderly patients
with AF. Therefore, simple clinical data predict the risk of
falls better than validated functional tests (30,31,32).
Furthermore, the high number of recurrences confirms
the higher risk for patients with previous falls (33,34).
In the literature, there is no clear definition of which
patients are at risk of falls.
The study population was relatively small, and therefore
inadequate to establish direct measures of risk prediction,
but it did allow us to evaluate the relationships between
many variables and the occurrence of falls.
In contrast with other studies, age, gender (35,36), use of
anti-hypertensive drugs (37), and cognitive impairment
were not associated with the occurrence of falls.
However, most of the variables considered as risk factors
were associated with the occurrence of falls, and it is known
that the risk of falls rises consistently with the number of
associated risk factors present (38).
Multivariate logistic regression showed that the use of
amiodarone, a diagnosis of diabetes and self-reported
difficulty maintaining balance (BOMFAQ) were indepen-
dent variables associated with the risk of falling. The
estimated probability of the risk of falling within a year
among patients with AF who did not present these three
independent variables was 16.3%, but it was almost six
times higher (97%) in the presence of all three variables.
Amiodarone is a highly effective drug, yet its use is
limited in chronic AF (39). A prescription of amiodarone is a
marker of disease severity associated with chronic AF,
which could lead to a higher risk of falls by postural
hypotension, embolic events and/or other heart rhythm
disturbances. On the other hand, the increased risk of falls
could be directly related to side effects of the drug, such as
retinal pigmentation, pulmonary fibrosis, thyroid dysfunc-
tions, optical and peripheral neuropathy, fatigue, tremors,
ataxia, sleep disorders, vertigo, and headaches.
In early reports, the frequencies of neurologic toxic effects
from amiodarone ranged from 27.5% to as high as 74% and
could have been related to a much higher daily dose
(40,41,42). The frequency of adverse neurologic effects in
longer-term amiodarone clinical trials has been much lower,
at less than 5% (43,44,45,46), as in the present study.
Diabetes could be associated with the risk of falls by
several mechanisms, such as micro- and macroangiopathy
(causing visual disturbances) and neuropathy (leading to
postural hypotension and compromising proprioception
and muscle strength).
Gerdhem et al. (10) concluded that for fall prediction in
elderly women, the more time-consuming objective func-
tional tests may be of limited importance compared to data
obtained from the clinical history. Similarly, the present
study emphasizes the value of clinical data in assessing the
risk of falls in elderly patients with AF. Risk factors for falls
are numerous and vary among patients and populations.
The results of the current study have important clinical
implications, as they could simplify the evaluation and
Table 2 - Logistic regression of the independent variables of the risk of falls.
Variable
Estimated
parameter
Standard
error p-value Odds ratio Confidence interval (95%)
Antiarrhythmic drug (YES/NO) 1.939 0.906 0.032 6.952 1.177 41.053
Comorbid diabetes mellitus (YES/NO) 1.591 0.629 0.011 4.909 1.432 16.832
BOMFAQ: Difficulty maintaining balance walking? (YES/NO) 1.768 0.507 ,0.001 5.862 2.171 15.828
Constant -1.630 0.457 ,0.001 0.196
CLINICS 2012;67(4):305-311 Predictors of the Risk of Falls
Santos ACS et al.
309
improve the management of elderly patients with AF at risk
of falling.
The generalization of the present findings to other
populations without or with chronic AF should be
performed with caution. This study was cross-sectional,
and it did not compare the AF group with a non-AF group
to determine whether AF itself increases the occurrence of
falls.
Furthermore, the studied population may represent a
select group with high functional status because a high
number of patients were not able to participate in the study.
Further prospective studies including a high number of AF
and non-AF elderly patients, comparing the predictive
value for falls of functional tests versus clinical data, are
needed to confirm the present findings.
In a group of elderly patients with chronic AF who were
relatively independent and able to attend an outpatient
clinic, the occurrence of falls with recurrence and con-
sequences was high. Self-reported difficulties maintaining
balance, the use of amiodarone and a diagnosis of diabetes
mellitus were identified as independent predictors of the
risk for falls. Thus, simple clinical data predicted falls better
than objective functional tests.
AUTHOR CONTRIBUTIONS
Santos ACS was responsible for the study planning and execution, material
collection, and manuscript writing. Nobre MRC designed the study. Amit
Nussbacker and Serro Azul JB were responsible for the manuscript writing.
Rodrigues GHP and Gebara OCE were responsible for the material
collection. Pierri H was responsible for the study planning. Wajngarten M
designed and planned the study and was also responsible for the
manuscript writing and study supervision.
REFERENCES
1. Maurer MS, Bloomfield DM. Atrial fibrillation and falls in the elderly.
Clin Geriatr Med. 2002;18(2):323-37, http://dx.doi.org/10.1016/S0749-
0690(02)00013-7.
2. Ott A, Breteler M, Bruyne M, Van Harskamp F, Grobbee DE, Hofman A.
Atrial fibrillation and dementia in a population based study: The
Rotterdam Study. Stroke. 1997;28(2):316-21, http://dx.doi.org/10.1161/
01.STR.28.2.316.
3. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, et al.
Effect of intensity of oral anticoagulantion on stroke severity and
mortality in atrial fibrilation. N Engl J Med. 2003;349(11):1019-26, http://
dx.doi.org/10.1056/NEJMoa022913.
4. European Heart Rhythm Association, Heart Rhythm Society, Fuster V,
Ryde´n LE, Cannom DS, Crijns HJ, et al. ACC/AHA/ESC 2006 guidelines
for the management of patients with atrial fibrillation--executive
summary: a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines and the European
Society of Cardiology Committee for Practice Guidelines (Writing
Committee to Revise the 2001 Guidelines for the Management of
Patients With. Atrial Fibrillation). J Am Coll Cardiol. 2006 Aug [cited
2011 Aug 31] 15;48(4):854-906. Erratum in: J Am Coll Cardiol.
2007;50(6):562.
5. Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, Rich
MW. Incidence of intracranial hemorrhage in patients with atrial
fibrillation who are prone to fall. Am J Med. 2005;118(6):612-7, http://
dx.doi.org/10.1016/j.amjmed.2005.02.022.
6. Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombo-
tic therapy for elderly patients with atrial fibrillation who are at risk for
falls. Arch Intern Med. 1999;159(7):677-85, http://dx.doi.org/10.1001/
archinte.159.7.677.
7. Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G, et al.
Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment:
Results of a Prospective Collaborative Study on Elderly Patients
Followed by Italian Centres for Anticoagulation. Circulation.
2011;124(7):824-9, http://dx.doi.org/10.1161/CIRCULATIONAHA.110.
007864.
8. The National Institute for Clinical Excellence (NICE). Clinical practice
guideline for the assessment and prevention of falls in older people
[cited Aug 31]. London: Royal College of Nursing (UK); Nov 2004.
Available from http://www.ncbi.nlm.nih.gov/books/NBK55851/pdf/
TOC.pdf
9. ProFaNE, School of Nursing, Midwifery and Social, Coupland III,
University of Manchester Oxford Road, Manchester M139PL [cited Aug
31]. Great Britain. Available from: www.profane.eu.org.
10. Gerdhem P, Ringsberg KA, Akesson K, Obrant KJ. Clinical history and
biology age predicted falls better than objective functional tests. J Clin
Epidemiol. 2005;58(3):226-32, http://dx.doi.org/10.1016/j.jclinepi.
2004.06.013.
11. Tinetti ME. Preventing Falls in Elderly Persons. N England J Med.
2003;348(1):42-4, http://dx.doi.org/10.1056/NEJMcp020719.
12. World Health Organization (WHO). Obesity Preventing and
Management Global Epidemic. Report of WHO Consultation on
Obesity. Geneva: Who; 1997.
13. Blay S, Ramos LR, Mari J. Validity of a Brazilian version of the older
Americans resources and services (OARS) mental health screening
questionnaire. J Am Geriatr Soc. 1988;36(8):687-92.
14. Perracini MR, Ramos LR. Fatores associados a quedas em uma coorte de
idosos residentes na comunidade. Brazilian Multidimensional
Functional Assessment Questionnarire (BOMFAQ) – versa˜o brasileira
do Multidimensional Functional Assessment Questionnaire. Rev Sau´de
Pu´blica. 2002;36(6):709-16.
15. Crum RM, Anthony JC, Basset SS, Folstein MF. Population-based norms
for Mini-Mental State Examination by age and educational level. JAMA.
1993;269(18):2420-1.
16. Brucki S, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugesto˜es
para o uso do Mini-Mental do estado mental no Brasil. Arq
Neuropsiquiatr 2003;61(3-B):777-81.
17. Spitzer RL, Williams JB, Kroenke K, Linzer M, de Gruy III FV, Hahn SR,
et al. Utility of a new procedure for diagnosing mental disorders in
primary care. The PRIME-MD 1000 study. JAMA. 1994;272(14):1749–5,
http://dx.doi.org/10.1001/jama.1994.03520220043029.
18. Fraguas R Jr, Henriques SG Jr, De Lucia MS, Iosifescu DV, Schwartz FH,
Menezes PR, et al. The detection of depression in medical setting: a study
with PRIME-MD. J Affect Disord. 2006;91(1):11-7, http://dx.doi.org/
10.1016/j.jad.2005.12.003.
19. Ferreira MHF, Dalgalarrondo P. Prevaleˆncia de Transtornos Depressivos
em hospital geral e validac¸a˜o do guia clı´nico Prime MD. In: XII
Congresso Interno de Iniciac¸a˜o Cientı´fica da UNICAMP, 2004. [citado
2011 Set 01]. Disponı´vel em: http://www.prp.unicamp.br/pibic/
congressos/xiicongresso/cdrom/pdfN/598.pdf.
20. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient
outcome in arthritis. Arthritis Rheum. 1980;23(2):137-45, http://
dx.doi.org/10.1002/art.1780230202.
21. Nondahl DM, Cruickshanks KJ, Wiley TL, Tweed TS, Klein R, Klein BE.
Accuracy of self-reported hearing loss. Audiology. 1998;35(5):295-301,
http://dx.doi.org/10.3109/00206099809072983.
22. Lehman LF Orsini MBP, Fuzikawa PL, Lima RC, Gonc¸alves SD. Avaliac¸a˜o
Neurolo´gica Simplificada. Belo Horizonte. ALM International, 1997. 104p.
Table 3 - Probability of the risk of a fall according to the simulation of combinations of independent variables.
Simulation
Variable combination
group Antiarrhythmia Diabetes mellitus Balance Estimated probability of fall Odds ratio
1 1 1 1 0.975126662 5.95
2 1 0 0 0.576711639 3.52
3 0 1 0 0.490315301 2.99
4 0 0 1 0.534614124 3.26
5 1 1 0 0.869927606 5.31
6 1 0 1 0.888720802 5.42
7 0 1 1 0.84937512 5.18
8 0 0 0 0.163861359 3.52
Predictors of the Risk of Falls
Santos ACS et al.
CLINICS 2012;67(4):305-311
310
CDU 616-002.73. Arquivo online: www.saude.pr.gov.br/arquivos/File/
hanseniase/public/ans.pdf.
23. Donders FC. Beitra¨ge zur pathologischen Anatomie des Auges. Graefes
Arch Clin Exp Ophthalmo. 1855;1(1):106-18.
24. Berg K, Wood-Dauphinee S, Williams JI. The Balance scale: Reliability
assessment for elderly residents and patients with an acute stroke.
Scand J Rehab Med. 1995;7(1):27-36.
25. Miyamoto ST, Lombardi Jr I, Berg Ko, Ramos LR, Natour J. Brasilian
version of the Berg balance scale. Braz J Med Biol Res. 2004;37(9):1411-21,
http://dx.doi.org/10.1590/S0100-879X2004000900017.
26. Tinetti ME. Performance-oriented assessment of mobility problems in
elderly patients. J Am Geriatr Soc. 1986;34(2):114-26.
27. Gomes GC. Traduc¸a˜o, adaptac¸a˜o cultural e exame das propriedades de
medida da escala ‘‘Performance Oriented Mobility Assessment’’ –
POMA para amostragem de idosos brasileiros institucionalizados
(dissertac¸a˜o). Campinas: Universidade Estadual de Campinas; 2003.
28. Podsiadlo D, Richard S. The Timed ‘‘Up & Go’’: a test of basic functional
mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-8.
29. Rosner B. Fundamentals of Biostatistics. 4a ed. New York: Duxbury
Press; 1994.
30. Andrade S, Santos SCM, Serro-Azul JB. Fibrilac¸a˜o Atrial. In: Wajngarten
M. Cardiogeriatria. Sa˜o Paulo: Roca; 2004. p. 132- 6.
31. Hill K, Schwarz J. Assessment and Management of falls in older people.
Intern Med J. 2004;34(9-10):557-64, http://dx.doi.org/10.1111/j.1445-
5994.2004.00668.x.
32. Feder G, Cryer C, Donovan S, Carter Y. Guidelines for the prevention of
falls in people over 65. BMJ. 2000;321(7267):1007-11, http://dx.doi.org/
10.1136/bmj.321.7267.1007.
33. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall?
JAMA. 2007;297(1):77-86, http://dx.doi.org/10.1001/jama.297.1.77.
34. Brotman DJ, Walker E, Laure MS, O’Brien RG. In search of fewer
independent risk factors. Arch Intern Med. 2005;165(2):138–45, http://
dx.doi.org/10.1001/archinte.165.2.138.
35. Feinberg WM, Blackshear A. Kronmal R, Hart RG. Prevalence, age,
distribution, and gender of patients with atrial fibrillation. Arch Intern
Med. 1995;155(5):469-73, http://dx.doi.org/10.1001/archinte.1995.
00430050045005.
36. Masud T, Morris RO. Epidemiology of falls. Age Ageing. 2001;30(Suppl
4):S3-7, http://dx.doi.org/10.1093/ageing/30.suppl_4.3.
37. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly
women and chronic diseases and drug use: cross sectional study. BMJ.
2003;327(7417):712-7, http://dx.doi.org/10.1136/bmj.327.7417.712.
38. Shumway- Cook A, Brauer S, Woollacott M. Predicting the probability
for falls in Community-dwelling older adults using the timed up & go
test. Phys Ther. 2000;80(9):896-903.
39. Cummings SR, Nevitt MC, Kidd SK. Forgetting falls. The limited
accuracy of recall of falls in the elderly. J AM Geriatr Soc. 1988;36(7):613-
6.
40. Maintenance of sinus rhythm in patient with atrial fibrillation: an
AFFIRM substudy of the first antiarrhythmic drug. AFFIRM First
Antiarrhythmic Drug Substudy Investigators. J Am Coll Cardiol.
2003;42(1):20-9.
41. Greene HL, Graham EL, Werner JA, Sears GK, Gross BW, Gorham JP,
et al. Toxic and therapeutic effects of amiodarone in the treatment of
cardiac arrhythmias. J Am Coll Cardiol. 1983;2(6):1114-28, http://
dx.doi.org/10.1016/S0735-1097(83)80338-6.
42. Charness ME, Morady F, Scheinman MM. Frequent neurologic toxicity
associated with amiodarone therapy. Neurology. 1984;34(5):669-7.
43. Palakurthy PR, Iyer V, Meckler RJ. Unusual neurotoxicity associated
with amiodarone therapy. Arch Intern Med. 1987;147(5):881-4, http://
dx.doi.org/10.1001/archinte.1987.00370050077013.
44. Ahmed S, Rienstra M, Crijns HJGM, Links TP, Wiesfeld ACP, Hillege
HL, et al. Continuous vs episodic prophylactic treatment with
amiodarone for the prevention of atrial fibrillation: a randomized trial.
JAMA. 2008;300(15):1784-92, http://dx.doi.org/10.1001/jama.300.
15.1784.
45. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome
after myocardial infarction in patients with frequent or repetitive
ventricular premature depolarisations: CAMIAT. Canadian
Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Lancet. 1997;349(9053):675-82.
46. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, et al.
European Myocardial Infarct Amiodarone Trial Investigators. Lancet.
1997;349(9053):667-74, http://dx.doi.org/10.1016/S0140-6736(96)09145-
3.
47. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of
low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30(3):791-
8, http://dx.doi.org/10.1016/S0735-1097(97)00220-9.
CLINICS 2012;67(4):305-311 Predictors of the Risk of Falls
Santos ACS et al.
311
